Acarbose

Overview

4.7 out of 5 (102 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

12 Feb 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

This program addresses the escalating challenge of type 2 diabetes, particularly in the USA, where clinicians are increasingly confronted with this condition among younger demographics. Acarbose, an approved adjunctive therapy for adults with type 2 diabetes, plays a crucial role in managing this prevalent health concern. The curriculum delves into the indications, contraindications, interactions, monitoring protocols, and other therapeutic aspects essential for an interprofessional healthcare team. By participating in this educational session, healthcare professionals will gain a comprehensive understanding of acarbose therapy, enabling them to make informed decisions and collaborate effectively to tailor treatment plans for improved patient outcomes.


UAN: JA4008338-0000-23-205-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the mechanism of action of acarbose.

  • Identify the potential adverse effects of acarbose.

  • Determine appropriate monitoring for acarbose therapy.

  • Compare interprofessional team strategies for improving care coordination and communication when using acarbose to improve patient outcomes for glucose control.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-205-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Harry A. on 9/26/2021

Erika A. on 9/30/2021

Patrick G. on 10/14/2021

mikaela v. on 10/17/2021

None

Katherine W. on 12/18/2021

Trenna R. on 12/31/2021

Just need the patient population with some of these disease states or medications.

Irvin C. on 1/11/2022

na

Lorraine C. on 1/22/2022

devin n. on 2/26/2022

Chandra D. on 10/4/2022

Frank K. on 4/18/2022

Amy R. on 5/6/2022

Mike B. on 5/13/2022

Ejaz J. on 5/22/2022

Charity L. on 5/30/2022

Stephen A. on 5/31/2022

Diana B. on 6/4/2022

Maylin G. on 10/10/2022

YVELINE F. on 12/5/2022

richard k. on 12/6/2022

Brian C. on 12/10/2022

Li Mei L. on 12/16/2022

Kecia T. on 12/26/2022

Natalie p. on 1/3/2023

Jacqueline M. on 1/25/2023

Scott B. on 1/27/2023

Elizabeth C. on 1/27/2023

Przemyslaw L. on 1/28/2023

Stephanie F. on 2/3/2023

Florence Y. on 2/17/2023

Bashiru B. on 2/22/2023

Julie E. on 2/23/2023

Rose F. on 3/1/2023

I appreciate this more in-depth assessment of acarbose and will be seeking out those StatPearls activities that similarly detail the other medication options for the diabetic state. I would also appreciate discussions regarding nondrug options for care, in particular the options that assist with weight loss.

Deborah B. on 3/2/2023

larry m. on 3/3/2023

Shirley A. on 4/4/2023

Mary C. on 4/26/2023

Lily L. on 4/30/2023

Rand P. on 5/2/2023

Nicole S. on 5/11/2023

Emily B. on 5/23/2023

Sharon B. on 5/27/2023

Arelly J. on 5/30/2023

Marc D. on 5/30/2023

David M. on 6/10/2023

Amber S. on 6/12/2023

Breena A. on 6/24/2023

Elise F. on 6/24/2023

Tara B. on 6/25/2023

Catherine R. on 7/9/2023

Debra W. on 7/19/2023

Shalamar S. on 7/29/2023

Snodgrass M. on 8/14/2023

Allynda H. on 8/20/2023

Jessica H. on 8/22/2023

Jennifer D. on 8/27/2023

Rita O. on 9/24/2023

Scott S. on 9/28/2023

Qefli N. on 10/4/2023

Melanie p. on 10/22/2023

Eileen J. on 10/30/2023

Lazo K. on 10/25/2023

Brenna B. on 10/29/2023

Ashok V. on 11/5/2023

Ali I. on 11/6/2023

Joanne Z. on 11/7/2023

Jennifer L. on 11/12/2023

Christopher K. on 11/18/2023

ravinder w. on 11/24/2023

Sahar E. on 11/26/2023

Kathryn g. on 11/27/2023

Nitin S. on 12/1/2023

Fabian L. on 12/9/2023

Julie C. on 12/15/2023

Steven L. on 12/29/2023

Maria R. on 12/30/2023

Andrea H. on 1/2/2024

Richard M. on 1/4/2024

Abigail M. on 1/6/2024

Theresa C. on 1/9/2024

William F. on 1/17/2024

Julia L. on 1/21/2024

Jesse I. on 1/30/2024

Erica G. on 1/30/2024

David S. on 2/1/2024

Lazo K. on 2/1/2024

Hugo N. on 2/7/2024

Ruth T. on 2/7/2024

Yongmei J. on 2/15/2024

Sidney m. on 2/16/2024

Patricia C. on 2/25/2024

Anuradha S. on 2/25/2024

Said a. on 2/25/2024

Mirna T. on 2/29/2024

Karen L. on 3/11/2024

JEANNETTE A. on 3/19/2024

Jennifer S. on 3/18/2024

Mary M. on 3/20/2024

No comment

Khodaidad B. on 3/27/2024

Mary C. on 3/31/2024

Gretchen M. on 4/3/2024

Casandra R. on 4/15/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6673 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7924.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$199 per 1 year per user